These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38276062)

  • 21. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction.
    Ouweneel DM; Eriksen E; Sjauw KD; van Dongen IM; Hirsch A; Packer EJ; Vis MM; Wykrzykowska JJ; Koch KT; Baan J; de Winter RJ; Piek JJ; Lagrand WK; de Mol BA; Tijssen JG; Henriques JP
    J Am Coll Cardiol; 2017 Jan; 69(3):278-287. PubMed ID: 27810347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock—a substudy of the IABP-SHOCK II-trial [corrected].
    Abdin A; Pöss J; Fuernau G; Ouarrak T; Desch S; Eitel I; de Waha S; Zeymer U; Böhm M; Thiele H
    Clin Res Cardiol; 2018 Jun; 107(6):517-523. PubMed ID: 29423774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Short and intermediate term clinical outcome in patients with cardiogenic shock treated with aortic counterpulsation].
    Fornaro G; Prando MD; Parodi F; Cordero G; Sansa M; Bongo AS; Campi A; Aralda D; Dellavesa P; Aina F; Lazzero M; Cernigliaro C
    G Ital Cardiol; 1996 Dec; 26(12):1385-99. PubMed ID: 9162668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of In-Hospital Mortality for Ischemic Cardiogenic Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation.
    Jeong JH; Kook H; Lee SH; Joo HJ; Park JH; Hong SJ; Kim MN; Park SM; Jung JS; Yang JH; Gwon HC; Ahn CM; Jang WJ; Kim HJ; Bae JW; Kwon SU; Lee WS; Jeong JO; Park SD; Lim SH; Lee J; Lee J; Yu CW
    J Am Heart Assoc; 2024 Feb; 13(4):e032701. PubMed ID: 38362865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gender difference in efficacy of intra-aortic balloon pump in acute myocardial infarction patients complicating with cardiogenic shock].
    Guo C; Teng HB; Zhang J; Li J; Xu HB; Wang XY; Yuan JS; Yang WX; Hu FH; Wu Y; Qiao SB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Aug; 48(8):675-681. PubMed ID: 32847324
    [No Abstract]   [Full Text] [Related]  

  • 26. "Smoker's paradox" in patients with cardiogenic shock complicating myocardial infarction - A substudy of the IABP-SHOCK II-trial and registry.
    Saad M; Fuernau G; Desch S; Eitel I; Jung C; Pöss J; Schneider S; Schuler G; Werdan K; Zeymer U; Thiele H
    Int J Cardiol; 2016 Nov; 222():775-779. PubMed ID: 27521557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of the Change in ESC Guidelines on Clinical Characteristics and Outcomes of Cardiogenic Shock Patients Receiving IABP Therapy.
    Nevzorov R; Daum A; Jafari J; Yosefy C; Gallego-Colon E
    Cardiovasc Revasc Med; 2020 Jan; 21(1):46-51. PubMed ID: 31759912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome.
    Prondzinsky R; Lemm H; Swyter M; Wegener N; Unverzagt S; Carter JM; Russ M; Schlitt A; Buerke U; Christoph A; Schmidt H; Winkler M; Thiery J; Werdan K; Buerke M
    Crit Care Med; 2010 Jan; 38(1):152-60. PubMed ID: 19770739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction.
    Pöss J; Köster J; Fuernau G; Eitel I; de Waha S; Ouarrak T; Lassus J; Harjola VP; Zeymer U; Thiele H; Desch S
    J Am Coll Cardiol; 2017 Apr; 69(15):1913-1920. PubMed ID: 28408020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does intra-aortic balloon support for myocardial infarction with cardiogenic shock improve outcome?
    Khashan MY; Pinsky MR
    Crit Care; 2013 Mar; 17(2):307. PubMed ID: 23472937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial.
    Prondzinsky R; Unverzagt S; Russ M; Lemm H; Swyter M; Wegener N; Buerke U; Raaz U; Ebelt H; Schlitt A; Heinroth K; Haerting J; Werdan K; Buerke M
    Shock; 2012 Apr; 37(4):378-84. PubMed ID: 22266974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial.
    Fuernau G; Fengler K; Desch S; Eitel I; Neumann FJ; Olbrich HG; de Waha A; de Waha S; Richardt G; Hennersdorf M; Empen K; Hambrecht R; Jung C; Böhm M; Pöss J; Strasser RH; Schneider S; Ouarrak T; Schuler G; Werdan K; Zeymer U; Thiele H
    Clin Res Cardiol; 2016 Dec; 105(12):1030-1041. PubMed ID: 27378612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VA-ECMO With IABP is Associated With Better Outcome Than VA-ECMO Alone in the Treatment of Cardiogenic Shock in ST-Elevation Myocardial Infarction.
    van den Brink FS; Zivelonghi C; Vossenberg TN; Bleeker GB; Winia VL; Sjauw KD; Ten Berg JM
    J Invasive Cardiol; 2021 May; 33(5):E387-E392. PubMed ID: 33893793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation.
    Schwarz B; Abdel-Wahab M; Robinson DR; Richardt G
    Med Klin Intensivmed Notfmed; 2016 Nov; 111(8):715-722. PubMed ID: 26596273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural history and risk factors of long-term mortality in acute coronary syndrome patients with cardiogenic shock.
    Kamiński KA; Tycińska AM; Stepek T; Szpakowicz A; Olędzka E; Dobrzycki S; Musiał WJ
    Adv Med Sci; 2014 Sep; 59(2):156-60. PubMed ID: 25323750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States.
    Shah M; Patnaik S; Patel B; Ram P; Garg L; Agarwal M; Agrawal S; Arora S; Patel N; Wald J; Jorde UP
    Clin Res Cardiol; 2018 Apr; 107(4):287-303. PubMed ID: 29134345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intra-Aortic Balloon Pump Counterpulsation during Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction and Cardiogenic Shock: Insights from the British Columbia Cardiac Registry.
    Iqbal MB; Robinson SD; Ding L; Fung A; Aymong E; Chan AW; Hodge S; Della Siega A; Nadra IJ;
    PLoS One; 2016; 11(2):e0148931. PubMed ID: 26870950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanical circulatory support with the Impella® LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: The IMPELLA-STIC randomized study.
    Bochaton T; Huot L; Elbaz M; Delmas C; Aissaoui N; Farhat F; Mewton N; Bonnefoy E;
    Arch Cardiovasc Dis; 2020 Apr; 113(4):237-243. PubMed ID: 31740272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effectiveness of intra-aortic balloon pump for myocardial infarction in patients with or without cardiogenic shock: a meta-analysis and systematic review.
    Zheng XY; Wang Y; Chen Y; Wang X; Chen L; Li J; Zheng ZG
    BMC Cardiovasc Disord; 2016 Jul; 16(1):148. PubMed ID: 27391391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of residual ischaemia in acute myocardial infarction complicated by cardiogenic shock undergoing venoarterial-extracorporeal membrane oxygenation.
    Hong D; Choi KH; Ahn CM; Yu CW; Park IH; Jang WJ; Kim HJ; Bae JW; Kwon SU; Lee HJ; Lee WS; Jeong JO; Park SD; Park TK; Lee JM; Song YB; Hahn JY; Choi SH; Gwon HC; Yang JH
    Eur Heart J Acute Cardiovasc Care; 2024 Jul; 13(7):525-534. PubMed ID: 38701179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.